VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 10/01/2021
** VAERS DATABASE Last updated: October 1, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.







Manufacturers

Total Manufacturer

Incidents per State

State Total
92,076
AK1,880
AL6,345
AR4,151
AS46
AZ14,991
CA66,887
CO12,550
CT8,943
DC1,795
DE2,009
FL42,724
FM4
GA17,031
GU124
HI2,580
IA4,919
ID2,892
IL22,128
IN24,197
KS5,047
KY9,111
LA5,500
MA15,718
MD13,434
ME3,351
MH8
MI20,971
MN13,585
MO10,747
MP30
MS3,198
MT2,477
NC18,051
ND1,501
NE3,109
NH3,218
NJ20,216
NM4,218
NV4,728
NY37,667
OH20,793
OK6,692
OR9,244
PA25,607
PR2,588
QM2
RI2,163
SC7,261
SD1,282
TN10,445
TX39,890
UT4,618
VA15,980
VI67
VT1,830
WA16,071
WI12,042
WV2,571
WY926
XB5
XL1
XV2

ID: 1580394
Sex: F
Age: 68
State: MN

Vax Date: 01/26/2021
Onset Date:
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Dysphagia, Epiglottitis

Symptoms: Weakness; Sore arm; Body aches , pain everywhere; Headache; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (Weakness), PAIN IN EXTREMITY (Sore arm), PAIN (Body aches , pain everywhere), HEADACHE (Headache) and NAUSEA (Nausea) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A.) for COVID-19 vaccination. No Medical History information was reported. On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ASTHENIA (Weakness), PAIN IN EXTREMITY (Sore arm), PAIN (Body aches , pain everywhere), HEADACHE (Headache) and NAUSEA (Nausea). At the time of the report, ASTHENIA (Weakness), PAIN IN EXTREMITY (Sore arm), PAIN (Body aches , pain everywhere), HEADACHE (Headache) and NAUSEA (Nausea) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No concomitant medications were reported No treatment information was provided.

Other Meds:

Current Illness:

ID: 1580395
Sex: M
Age:
State: NY

Vax Date: 01/16/2021
Onset Date: 01/24/2021
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Anxiety, Dyspnoea

Symptoms: This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills), PYREXIA (fever of 101.5?F) and HEADACHE (headache) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination. No Medical History information was reported. On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Jan-2021, the patient experienced CHILLS (chills). On 25-Jan-2021, the patient experienced PYREXIA (fever of 101.5?F) and HEADACHE (headache). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency. On 26-Jan-2021, CHILLS (chills), PYREXIA (fever of 101.5?F) and HEADACHE (headache) had resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 25-Jan-2021, Body temperature: 101.5 degree Fahrenheit. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown. No concomitant medications were reported.

Other Meds:

Current Illness:

ID: 1580396
Sex: F
Age:
State: FL

Vax Date: 01/04/2021
Onset Date: 02/02/2021
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Chest discomfort, Dysphagia, Pain in extremity, Visual impairment

Symptoms: feels sick; earache; neck is rigid; sore at the injection site; horrible headache; fever; This spontaneous case was reported by a nurse and describes the occurrence of VACCINATION COMPLICATION (feels sick), EAR PAIN (earache), MUSCULOSKELETAL STIFFNESS (neck is rigid), INJECTION SITE PAIN (sore at the injection site) and HEADACHE (horrible headache) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011L20A and 012M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included No adverse event (No reported medical history). Concomitant products included DOCUSATE SODIUM (COLACE), MACROGOL 3350 (MIRALAX) and PROBIOTICS NOS for an unknown indication. On 04-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 02-Feb-2021, the patient experienced VACCINATION COMPLICATION (feels sick), EAR PAIN (earache), MUSCULOSKELETAL STIFFNESS (neck is rigid), INJECTION SITE PAIN (sore at the injection site), HEADACHE (horrible headache) and PYREXIA (fever). At the time of the report, VACCINATION COMPLICATION (feels sick), EAR PAIN (earache), MUSCULOSKELETAL STIFFNESS (neck is rigid), INJECTION SITE PAIN (sore at the injection site), HEADACHE (horrible headache) and PYREXIA (fever) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.

Other Meds: COLACE; MIRALAX; PROBIOTICS NOS

Current Illness:

ID: 1580397
Sex: M
Age: 51
State: FL

Vax Date: 01/08/2021
Onset Date: 01/16/2021
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Dizziness, Fatigue, Mobility decreased

Symptoms: He had COVID-19 after vaccination; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (He had COVID-19 after vaccination) in a 51-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination. Concomitant products included GUSELKUMAB (TREMFYA), NEBIVOLOL HYDROCHLORIDE (BYSTOLIC) and ACETYLSALICYLIC ACID (BABY ASPIRIN) for an unknown indication. On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Jan-2021, the patient experienced COVID-19 (He had COVID-19 after vaccination). On 24-Jan-2021, COVID-19 (He had COVID-19 after vaccination) had resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 18-Jan-2021, SARS-CoV-2 test: covid-19 Positive. On 24-Jan-2021, SARS-CoV-2 test: covid-19 Negative. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown. Patient was treated for Covid-19 infection with Regeneron Monoclonal antibody, intravenously on 20Jan2021

Other Meds: TREMFYA; BYSTOLIC; BABY ASPIRIN

Current Illness:

ID: 1580398
Sex: F
Age: 68
State: CA

Vax Date: 01/26/2021
Onset Date:
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: delayed reaction arm red spot; delayed reaction severe itching; arm pain; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (delayed reaction arm red spot), INJECTION SITE PRURITUS (delayed reaction severe itching) and PAIN IN EXTREMITY (arm pain) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination. The patient's past medical history included No adverse event (No reported medical history.). On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE ERYTHEMA (delayed reaction arm red spot), INJECTION SITE PRURITUS (delayed reaction severe itching) and PAIN IN EXTREMITY (arm pain). At the time of the report, VACCINATION SITE ERYTHEMA (delayed reaction arm red spot), INJECTION SITE PRURITUS (delayed reaction severe itching) and PAIN IN EXTREMITY (arm pain) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant information provided. No treatment information provided.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.

Other Meds:

Current Illness:

ID: 1580399
Sex: F
Age: 75
State: NV

Vax Date: 01/12/2021
Onset Date: 01/12/2021
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Chills, Confusional state, Eye inflammation, Headache, Laboratory test

Symptoms: Mild Soreness; Headache; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Mild Soreness) and HEADACHE (Headache) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20-24) for COVID-19 vaccination. No Medical History information was reported. On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Jan-2021, the patient experienced PAIN (Mild Soreness) and HEADACHE (Headache). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) for Pain and Headache, at an unspecified dose and frequency. At the time of the report, PAIN (Mild Soreness) and HEADACHE (Headache) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown. No relevant concomitant medications were reported.

Other Meds:

Current Illness:

ID: 1580400
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Pyrexia, White blood cell count decreased

Symptoms: adverse reaction; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE REACTION (adverse reaction) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ADVERSE REACTION (adverse reaction). At the time of the report, ADVERSE REACTION (adverse reaction) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No relevant concomitant medications were reported. No treatment information was provided.

Other Meds:

Current Illness:

ID: 1580401
Sex: F
Age: 73
State: FL

Vax Date: 01/14/2021
Onset Date: 01/15/2021
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Pharyngeal swelling

Symptoms: Joint pain; Muscle pain; More hot flashes than usual; Red area underneath the injection site; Arm was sore; A spontaneous report was received from a consumer concerning a 73-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced joint pain, muscle pain, more hot flashes than usual, red area underneath the injection site and sore arm. The patient's medical history included hot flashes. Relevant concomitant medications included Estrogen for hot flashes(since 20 years). On 14 Jan 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot batch: 013L20A) intramuscularly on her left arm, for prophylaxis of COVID-19 infection. On 14 Jan 2021, the patient experienced sore arm and lasted for few days. On an unknown date,she also started to have joint andcmuscle pain. She stated that she usually had hot flashes, but that approximately a week and a half later from getting the vaccine, she seemed to have a lot more and that feeling lasted for a couple of days. Also, underneath the injection site, there was a little red area. No treatment information was provided. Action taken with mRNA-1273 in response to the events was unknown. The outcome of event(s) joint pain, muscle pain, more hot flashes than usual, red area underneath the injection site and sore arm were Unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.

Other Meds: ESTROGEN

Current Illness:

ID: 1580402
Sex: M
Age: 78
State: TX

Vax Date: 01/20/2021
Onset Date:
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Abdominal pain, Chills, Sleep disorder

Symptoms: Soreness at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Soreness at injection site) in a 78-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (Soreness at injection site). At the time of the report, VACCINATION SITE PAIN (Soreness at injection site) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No relevant concomitant medications were reported. No treatment information was provided.

Other Meds:

Current Illness:

ID: 1580403
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Diarrhoea, Nasal congestion

Symptoms: bruise; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of CONTUSION (bruise) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced CONTUSION (bruise). At the time of the report, CONTUSION (bruise) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No relevant concomitant medications were reported. No treatment information was provided. Reporter did not allow further contact

Other Meds:

Current Illness:

ID: 1580404
Sex: M
Age:
State: CA

Vax Date: 01/28/2021
Onset Date: 01/28/2021
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling

Symptoms: Sore Arm; Bleeding on the injection site immediately after injection; Rush of warmth from upper chest going to his head; A spontaneous report was received from a Consumer concerning a 72-years-old male patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced little bleeding on the injection site immediately after injection, rush of warmth from upper chest going to his head and sore arm. The patient's medical history was not provided. No relevant concomitant medications were reported. On 28 Jan 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot batch: 042L20A) intramuscularly in the left arm for prophylaxis of COVID-19 infection. On 28 Jan 2021, the patient experienced little bleeding on the injection site immediately after injection and rush of warmth from upper chest going to his head. On 29 Jan 2021, the patient experienced the events sore arm. No lab data was provided. No treatment information was provided. Action taken with mRNA-1273 in response to the events was unknown. On 28 Jan 2021 the outcome of events bleeding on the injection site immediately after injection and rush of warmth from upper chest going to his head- was resolved. The outcome of event-sore arm -was considered to be unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. Further information has been requested

Other Meds:

Current Illness:

ID: 1580405
Sex: M
Age: 59
State: TX

Vax Date: 01/25/2021
Onset Date:
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Rash, Urticaria

Symptoms: Pain at the injection site for 2 days and nothing more; A spontaneous report ( was received from a Consumer concerning a 59-years-old, male patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced pain at the injection site for two days. The patient's medical history was not provided. Concomitant medications reported included metformin for diabetes and lisinopril for blood pressure. On 25 Jan 2021, prior to the onset of the event the patient received their dose of mRNA-1273 (Batch Number: 00420A) intramuscularly in the right arm for prophylaxis of COVID-19 infection. On an unspecified date, the patient experienced pain at the injection site for 2 days and nothing more. No treatment information was provided. Action taken with mRNA-1273 in response to the event pain at the injection site for 2 days was not reported. The outcome of the event pain at the injection site for 2 days was considered resolved (for 2 days) on an unspecified date.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the onset date of the event, a causal relationship cannot be excluded.

Other Meds: METFORMIN; LISINOPRIL

Current Illness: Diabetes; Hypertension (Blood pressure)

ID: 1580406
Sex: F
Age: 72
State: IL

Vax Date: 01/30/2021
Onset Date: 01/30/2021
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Blood pressure decreased, Chest pain, Chills, Confusional state, Decreased appetite

Symptoms: This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE ERYTHEMA (Red large circle around the injection site), CONTUSION (Bruise), INJECTION SITE PRURITUS (injection site Itching) and INJECTION SITE WARMTH (Injection site hot to the touch) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012MZ0A) for COVID-19 vaccination. Concomitant products included LISINOPRIL, OMEPRAZOLE and LOFEXIDINE for an unknown indication. On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Jan-2021, the patient experienced INJECTION SITE ERYTHEMA (Red large circle around the injection site), CONTUSION (Bruise), INJECTION SITE PRURITUS (injection site Itching) and INJECTION SITE WARMTH (Injection site hot to the touch). At the time of the report, INJECTION SITE ERYTHEMA (Red large circle around the injection site), CONTUSION (Bruise), INJECTION SITE PRURITUS (injection site Itching) and INJECTION SITE WARMTH (Injection site hot to the touch) was resolving. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Treatment details included Hydrocortisone

Other Meds: LISINOPRIL; OMEPRAZOLE; LOFEXIDINE

Current Illness:

ID: 1580407
Sex: M
Age: 80
State: LA

Vax Date: 01/22/2021
Onset Date: 01/26/2021
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Dyspnoea, Fatigue, Feeling abnormal, Head discomfort, Headache

Symptoms: Lethargic; FELT HORRIBLE; fever; This spontaneous case was reported by a consumer and describes the occurrence of LETHARGY (Lethargic), FEELING ABNORMAL (FELT HORRIBLE) and PYREXIA (fever) in an 80-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination. No Medical History information was reported. On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Jan-2021, the patient experienced LETHARGY (Lethargic), FEELING ABNORMAL (FELT HORRIBLE) and PYREXIA (fever). At the time of the report, LETHARGY (Lethargic), FEELING ABNORMAL (FELT HORRIBLE) and PYREXIA (fever) had resolved. No relevant concomitant medications were reported. The patient had second dose of Moderna on an unspecified date and had no adverse events. Most recent FOLLOW-UP information incorporated above includes: On 06-Jul-2021: No adverse reaction after the second dose.

Other Meds:

Current Illness:

ID: 1580408
Sex: F
Age:
State: TN

Vax Date: 12/30/2020
Onset Date:
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Heart rate decreased, Heart rate increased, Hypertension, Injection site pain, Musculoskeletal chest pain

Symptoms: Body temperature 102?F; Temperature ranging between 99.8?F and 99.2 ?F; This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of BODY TEMPERATURE INCREASED (Body temperature 102?F) and BODY TEMPERATURE INCREASED (Temperature ranging between 99.8?F and 99.2 ?F) in a 32-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination. No Medical History information was reported. On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced BODY TEMPERATURE INCREASED (Body temperature 102?F) and BODY TEMPERATURE INCREASED (Temperature ranging between 99.8?F and 99.2 ?F). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, BODY TEMPERATURE INCREASED (Body temperature 102?F) and BODY TEMPERATURE INCREASED (Temperature ranging between 99.8?F and 99.2 ?F) had not resolved. Not Provided DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature increased: 102*F, 99.8*F, 99.2*F. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.

Other Meds:

Current Illness:

ID: 1580409
Sex: F
Age: 38
State: AZ

Vax Date: 01/22/2021
Onset Date: 01/22/2021
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Nausea, Pain, Pain in extremity, Paraesthesia oral, Pyrexia

Symptoms: feeling feverish, nausea, unnormal breathing, electricity on both of her hands, numbness on her; feeling disoriented; fatigue; foggy brain; sluggish; sogginess; eeling feverish, nausea, unnormal breathing, electricity on both of her hands, numbness on her; feeling feverish, nausea, unnormal breathing, electricity on both of her hands, numbness on her; feeling feverish, nausea, unnormal breathing, electricity on both of her hands, numbness on her; numbness, tingling and pain on her arm, fever, vomiting; numbness, tingling and pain on her arm, fever, vomiting; numbness, tingling and pain on her arm, fever, vomiting; numbness, tingling and pain on her arm, fever, vomiting; vomiting; no appetite; mouth sores, headache, diarrhea; mouth sores, headache, diarrhea; mouth sores, headache, diarrhea; This spontaneous case was reported by a consumer and describes the occurrence of ORAL PAIN (mouth sores, headache, diarrhea), HEADACHE (mouth sores, headache, diarrhea), DIARRHOEA (mouth sores, headache, diarrhea), PARAESTHESIA (numbness, tingling and pain on her arm, fever, vomiting) and HYPOAESTHESIA (numbness, tingling and pain on her arm, fever, vomiting) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Concurrent medical conditions included Lipoprotein deficiency. On 22-Jan-2021 at 12:00 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Jan-2021, the patient experienced ORAL PAIN (mouth sores, headache, diarrhea), HEADACHE (mouth sores, headache, diarrhea), DIARRHOEA (mouth sores, headache, diarrhea) and DECREASED APPETITE (no appetite). On 27-Jan-2021, the patient experienced PARAESTHESIA (numbness, tingling and pain on her arm, fever, vomiting), HYPOAESTHESIA (numbness, tingling and pain on her arm, fever, vomiting), PAIN IN EXTREMITY (numbness, tingling and pain on her arm, fever, vomiting), PYREXIA (numbness, tingling and pain on her arm, fever, vomiting) and VOMITING (vomiting). On 28-Jan-2021, the patient experienced RESPIRATION ABNORMAL (eeling feverish, nausea, unnormal breathing, electricity on both of her hands, numbness on her), PARAESTHESIA (feeling feverish, nausea, unnormal breathing, electricity on both of her hands, numbness on her) and HEADACHE (feeling feverish, nausea, unnormal breathing, electricity on both of her hands, numbness on her). On an unknown date, the patient experienced NAUSEA (feeling feverish, nausea, unnormal breathing, electricity on both of her hands, numbness on her), FATIGUE (fatigue), FEELING ABNORMAL (foggy brain), SLUGGISHNESS (sluggish) and HYPERHIDROSIS (sogginess). an unknown date, the patient experienced DISORIENTATION (feeling disoriented). The patient was treated with IBUPROFEN at an unspecified dose and frequency; PARACETAMOL (TYLENOL) at an unspecified dose and frequency and EPHEDRINE at an unspecified dose and frequency. At the time of the report, ORAL PAIN (mouth sores, headache, diarrhea), HEADACHE (mouth sores, headache, diarrhea), DIARRHOEA (mouth sores, headache, diarrhea), PARAESTHESIA (numbness, tingling and pain on her arm, fever, vomiting), HYPOAESTHESIA (numbness, tingling and pain on her arm, fever, vomiting), PAIN IN EXTREMITY (numbness, tingling and pain on her arm, fever, vomiting), PYREXIA (numbness, tingling and pain on her arm, fever, vomiting), VOMITING (vomiting), DECREASED APPETITE (no appetite), NAUSEA (feeling feverish, nausea, unnormal breathing, electricity on both of her hands, numbness on her), RESPIRATION ABNORMAL (eeling feverish, nausea, unnormal breathing, electricity on both of her hands, numbness on her), PARAESTHESIA (feeling feverish, nausea, unnormal breathing, electricity on both of her hands, numbness on her), HEADACHE (feeling feverish, nausea, unnormal breathing, electricity on both of her hands, numbness on her), DISORIENTATION (feeling disoriented), FATIGUE (fatigue), FEELING ABNORMAL (foggy brain), SLUGGISHNESS (sluggish) and HYPERHIDROSIS (sogginess) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In January 2021, SARS-CoV-2 antibody test: negative (Negative) negative. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No concomitant medications was reported. Most recent FOLLOW-UP information incorporated above includes: On 13-Apr-2021: No specific follow-up information recorded.

Other Meds:

Current Illness:

ID: 1580410
Sex: F
Age: 25
State: OR

Vax Date: 01/23/2021
Onset Date: 01/23/2021
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: SARS-CoV-2 antibody test, SARS-CoV-2 test negative

Symptoms: Pain behind eyes; Headaches; nausea; This spontaneous case was reported by a consumer and describes the occurrence of EYE PAIN (Pain behind eyes), HEADACHE (Headaches) and NAUSEA (nausea) in a 25-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 057620A) for COVID-19 vaccination. Concomitant products included OMEPRAZOLE MAGNESIUM (PRILOSEC [OMEPRAZOLE MAGNESIUM]), OXYBUTYNIN and MULTIVITAMIN [VITAMINS NOS] for an unknown indication. On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Jan-2021, the patient experienced EYE PAIN (Pain behind eyes), HEADACHE (Headaches) and NAUSEA (nausea). The patient was treated with PARACETAMOL (TYLENOL) for Headache, at an unspecified dose and frequency. At the time of the report, EYE PAIN (Pain behind eyes), HEADACHE (Headaches) and NAUSEA (nausea) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.

Other Meds: PRILOSEC [OMEPRAZOLE MAGNESIUM]; OXYBUTYNIN; MULTIVITAMIN [VITAMINS NOS]

Current Illness:

ID: 1580411
Sex: F
Age: 78
State:

Vax Date: 01/26/2021
Onset Date: 01/26/2021
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Ear pain, Hypoaesthesia

Symptoms: Feeling light headed; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Feeling light headed) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination. No Medical History information was reported. On 26-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Jan-2021, the patient experienced DIZZINESS (Feeling light headed). At the time of the report, DIZZINESS (Feeling light headed) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No relevant concomitant medications were reported. No treatment information was provided.

Other Meds:

Current Illness:

ID: 1580412
Sex: F
Age: 69
State: CA

Vax Date: 01/21/2021
Onset Date: 01/21/2021
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Dizziness, Dysgeusia

Symptoms: faint, cold/clammy, and sweating.; dizziness; blood pressure changes; chills; fatigue that would come and go; severe itching on both her forearms.; lips on the inside of her mouth swelled up on one side; This spontaneous case was reported by a consumer and describes the occurrence of MOUTH SWELLING (lips on the inside of her mouth swelled up on one side), PRURITUS (severe itching on both her forearms.), FATIGUE (fatigue that would come and go), CHILLS (chills) and DIZZINESS (dizziness) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced MOUTH SWELLING (lips on the inside of her mouth swelled up on one side). On 22-Jan-2021, the patient experienced PRURITUS (severe itching on both her forearms.). On 23-Jan-2021, the patient experienced FATIGUE (fatigue that would come and go). On 31-Jan-2021, the patient experienced CHILLS (chills). On 02-Feb-2021, the patient experienced DIZZINESS (dizziness) and BLOOD PRESSURE ABNORMAL (blood pressure changes). On an unknown date, the patient experienced NASOPHARYNGITIS (faint, cold/clammy, and sweating.). The patient was treated with CETIRIZINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE (ZYRTEC PLUS) for Itching, at an unspecified dose and frequency. At the time of the report, MOUTH SWELLING (lips on the inside of her mouth swelled up on one side), PRURITUS (severe itching on both her forearms.), FATIGUE (fatigue that would come and go), CHILLS (chills), DIZZINESS (dizziness), BLOOD PRESSURE ABNORMAL (blood pressure changes) and NASOPHARYNGITIS (faint, cold/clammy, and sweating.) outcome was unknown. Not Provided DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 02-Feb-2021, Blood pressure measurement: 61/45, 71/49, 107/64, 109/65, 82/53, 71/53. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.

Other Meds:

Current Illness:

ID: 1580413
Sex: F
Age: 68
State: NJ

Vax Date: 01/15/2021
Onset Date: 01/15/2021
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Blood pressure increased, Chest discomfort, Heart rate increased

Symptoms: large pink circle at the injection site; Discoloration at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE DISCOLOURATION (Discoloration at the injection site) and INJECTION SITE DISCOLOURATION (large pink circle at the injection site) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination. No Medical History information was reported. On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Jan-2021, the patient experienced INJECTION SITE DISCOLOURATION (Discoloration at the injection site). On 28-Jan-2021, the patient experienced INJECTION SITE DISCOLOURATION (large pink circle at the injection site). At the time of the report, INJECTION SITE DISCOLOURATION (Discoloration at the injection site) and INJECTION SITE DISCOLOURATION (large pink circle at the injection site) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No Concomitant Medications were provided. Treatment Medications were not taken by the patient.

Other Meds:

Current Illness:

ID: 1580414
Sex: F
Age: 63
State: NJ

Vax Date: 01/18/2021
Onset Date: 01/25/2021
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Lymph node pain, Lymphadenopathy

Symptoms: redness at injection site; itchy; arm swelling; circle at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (arm swelling), INJECTION SITE REACTION (circle at injection site), INJECTION SITE ERYTHEMA (redness at injection site) and INJECTION SITE PRURITUS (itchy) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination. Concurrent medical conditions included Glaucoma (contraindicated to take oral Benadryl because of her Glaucoma). On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Jan-2021, the patient experienced VACCINATION SITE SWELLING (arm swelling), INJECTION SITE REACTION (circle at injection site) and INJECTION SITE PRURITUS (itchy). On an unknown date, the patient experienced INJECTION SITE ERYTHEMA (redness at injection site). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) (topical) at a dose of 1 dosage form. At the time of the report, VACCINATION SITE SWELLING (arm swelling), INJECTION SITE REACTION (circle at injection site), INJECTION SITE ERYTHEMA (redness at injection site) and INJECTION SITE PRURITUS (itchy) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medications were not reported. Most recent FOLLOW-UP information incorporated above includes: On 06-Jul-2021: no significant information.

Other Meds:

Current Illness: Glaucoma (contraindicated to take oral Benadryl because of her Glaucoma)

ID: 1580415
Sex: F
Age: 67
State: CA

Vax Date: 01/29/2021
Onset Date: 01/01/2021
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Unevaluable event

Symptoms: sharp pain in the right side of her body on the lung and bra line; ache left arm; fatigue; muscle pain; joint pain; inflammation on the lungs and ribs; This spontaneous case was reported by a consumer and describes the occurrence of PULMONARY PAIN (sharp pain in the right side of her body on the lung and bra line), PNEUMONITIS (inflammation on the lungs and ribs), VACCINATION SITE PAIN (ache left arm), FATIGUE (fatigue) and MYALGIA (muscle pain) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 062G20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Concomitant products included VITAMINS NOS for Vitamin supplementation. On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Jan-2021, the patient experienced PNEUMONITIS (inflammation on the lungs and ribs). On 29-Jan-2021, the patient experienced VACCINATION SITE PAIN (ache left arm), FATIGUE (fatigue), MYALGIA (muscle pain) and ARTHRALGIA (joint pain). On 31-Jan-2021, the patient experienced PULMONARY PAIN (sharp pain in the right side of her body on the lung and bra line). The patient was treated with NAPROXEN SODIUM (ALEVE) for Pain, at an unspecified dose and frequency. At the time of the report, PULMONARY PAIN (sharp pain in the right side of her body on the lung and bra line), PNEUMONITIS (inflammation on the lungs and ribs), VACCINATION SITE PAIN (ache left arm), FATIGUE (fatigue), MYALGIA (muscle pain) and ARTHRALGIA (joint pain) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.

Other Meds: VITAMINS NOS

Current Illness:

ID: 1580416
Sex: M
Age: 48
State: NJ

Vax Date: 01/20/2021
Onset Date: 01/25/2021
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Injection site pain, Myalgia, Pyrexia

Symptoms: where he got the injection, is yellow; Sore arm where they gave him the injection; His armpit started swelling up; This spontaneous case was reported by an other and describes the occurrence of VACCINATION SITE DISCOLOURATION (where he got the injection, is yellow), LYMPHADENOPATHY (His armpit started swelling up) and VACCINATION SITE PAIN (Sore arm where they gave him the injection) in a 48-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination. No Medical History information was reported. On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Jan-2021, the patient experienced LYMPHADENOPATHY (His armpit started swelling up). On 26-Jan-2021, the patient experienced VACCINATION SITE DISCOLOURATION (where he got the injection, is yellow) and VACCINATION SITE PAIN (Sore arm where they gave him the injection). At the time of the report, VACCINATION SITE DISCOLOURATION (where he got the injection, is yellow), LYMPHADENOPATHY (His armpit started swelling up) and VACCINATION SITE PAIN (Sore arm where they gave him the injection) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No relevant concomitant medications were provided. Treatment information was not provided.

Other Meds:

Current Illness:

ID: 1580417
Sex: U
Age:
State:

Vax Date: 01/25/2021
Onset Date:
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Injection site pain, Pain

Symptoms: I've got some reactions through the day; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (I've got some reactions through the day) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No medical history was provided by the reporter. Concomitant products included ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) for an unknown indication. On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced VACCINATION COMPLICATION (I've got some reactions through the day). At the time of the report, VACCINATION COMPLICATION (I've got some reactions through the day) outcome was unknown. Very limited information regarding this event has been provided at this time. Further information has been requested.; Sender's Comments: Very limited information regarding this event has been provided at this time. Further information has been requested.

Other Meds: ASPIRIN (E.C.)

Current Illness:

ID: 1580418
Sex: M
Age: 80
State: AZ

Vax Date: 01/22/2021
Onset Date:
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Injection site pain, Menorrhagia

Symptoms: This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (itching on left palm of hand) and URTICARIA (hives on thighs, butt, and lower chest) in an 80-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination. Concomitant products included ALLOPURINOL, LOSARTAN, DEXLANSOPRAZOLE (DEXILANT), CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000), TOLTERODINE TARTRATE and ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) for an unknown indication. On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRURITUS (itching on left palm of hand) and URTICARIA (hives on thighs, butt, and lower chest). At the time of the report, PRURITUS (itching on left palm of hand) and URTICARIA (hives on thighs, butt, and lower chest) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.

Other Meds: ALLOPURINOL; LOSARTAN; DEXILANT; VITAMIN D 2000; TOLTERODINE TARTRATE; ASPIRIN (E.C.)

Current Illness:

ID: 1580419
Sex: F
Age: 73
State: TX

Vax Date: 01/25/2021
Onset Date: 01/27/2021
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Arthralgia, Chills, Headache, Mobility decreased, Myalgia

Symptoms: RED AT INJECTION SITE; SWOLLEN AT INJECTION SITE; ITCHING AT INJECTION SITE; HOT AT INJECTION SITE; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE ERYTHEMA (RED AT INJECTION SITE), INJECTION SITE SWELLING (SWOLLEN AT INJECTION SITE), INJECTION SITE PRURITUS (ITCHING AT INJECTION SITE) and INJECTION SITE WARMTH (HOT AT INJECTION SITE) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M20A) for COVID-19 vaccination. No Medical History information was reported. On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, the patient experienced INJECTION SITE ERYTHEMA (RED AT INJECTION SITE), INJECTION SITE SWELLING (SWOLLEN AT INJECTION SITE), INJECTION SITE PRURITUS (ITCHING AT INJECTION SITE) and INJECTION SITE WARMTH (HOT AT INJECTION SITE). At the time of the report, INJECTION SITE ERYTHEMA (RED AT INJECTION SITE), INJECTION SITE SWELLING (SWOLLEN AT INJECTION SITE), INJECTION SITE PRURITUS (ITCHING AT INJECTION SITE) and INJECTION SITE WARMTH (HOT AT INJECTION SITE) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No relevant concomitant medications were reported. No treatment information was provided.

Other Meds:

Current Illness:

ID: 1580420
Sex: F
Age:
State: CT

Vax Date: 01/20/2021
Onset Date: 01/21/2021
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Nausea, Pain in extremity, Pyrexia

Symptoms: chills; head felt heavy and achy; head felt heavy and achy; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills), HEAD DISCOMFORT (head felt heavy and achy) and HEADACHE (head felt heavy and achy) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination. No Medical History information was reported. On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced CHILLS (chills), HEAD DISCOMFORT (head felt heavy and achy) and HEADACHE (head felt heavy and achy). At the time of the report, CHILLS (chills), HEAD DISCOMFORT (head felt heavy and achy) and HEADACHE (head felt heavy and achy) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No relevant concomitant medications were reported. No treatment information was provided.

Other Meds:

Current Illness:

ID: 1580421
Sex: F
Age: 79
State: TX

Vax Date: 01/13/2021
Onset Date: 01/13/2021
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Chills, Fatigue, Headache, Myalgia

Symptoms: broke up redness/ still red; swollen; still soreness; extremely tired and weak for a few days; recovering color seems to go away but comes back, it's weird; chronic headache and after the shot became worse; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE ERYTHEMA (broke up redness/ still red), VACCINATION SITE SWELLING (swollen), VACCINATION SITE PAIN (still soreness), FATIGUE (extremely tired and weak for a few days) and HEADACHE (chronic headache and after the shot became worse) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041120A Not sure) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Concomitant products included PANTOPRAZOLE, GABAPENTIN and CALCIUM for an unknown indication. On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Jan-2021, the patient experienced HEADACHE (chronic headache and after the shot became worse). On an unknown date, the patient experienced INJECTION SITE ERYTHEMA (broke up redness/ still red), VACCINATION SITE SWELLING (swollen), VACCINATION SITE PAIN (still soreness), FATIGUE (extremely tired and weak for a few days) and DYSCHROMATOPSIA (recovering color seems to go away but comes back, it's weird). At the time of the report, INJECTION SITE ERYTHEMA (broke up redness/ still red), VACCINATION SITE SWELLING (swollen), VACCINATION SITE PAIN (still soreness), FATIGUE (extremely tired and weak for a few days), HEADACHE (chronic headache and after the shot became worse) and DYSCHROMATOPSIA (recovering color seems to go away but comes back, it's weird) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Treatment information information reported was Ibuprofen but only the first day.

Other Meds: PANTOPRAZOLE; GABAPENTIN; CALCIUM

Current Illness:

ID: 1580422
Sex: M
Age: 66
State: NV

Vax Date: 01/30/2021
Onset Date: 01/31/2021
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Headache, Heart rate increased, Injection site erythema, Injection site pain, Injection site swelling

Symptoms: Blackness at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE DISCOLOURATION (Blackness at the injection site) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Jan-2021, the patient experienced VACCINATION SITE DISCOLOURATION (Blackness at the injection site). At the time of the report, VACCINATION SITE DISCOLOURATION (Blackness at the injection site) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.

Other Meds:

Current Illness:

ID: 1580423
Sex: F
Age: 74
State: NV

Vax Date: 02/02/2021
Onset Date: 02/09/2021
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Nausea

Symptoms: Soreness in the right arm; Itching; Redness; Swelling; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PAIN IN EXTREMITY (Soreness in the right arm), PRURITUS (Itching), ERYTHEMA (Redness) and SWELLING (Swelling) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination. The patient's past medical history included No adverse event (No medical history reported.). Concomitant products included VITAMIN 15 for Vitamin supplementation, LEVOTHYROXINE SODIUM (SYNTHROID) for an unknown indication. On 02-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, the patient experienced PRURITUS (Itching), ERYTHEMA (Redness) and SWELLING (Swelling). On 10-Feb-2021, the patient experienced PAIN IN EXTREMITY (Soreness in the right arm). The patient was treated with ACETAMINOPHEN for Rash, at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (Soreness in the right arm), PRURITUS (Itching), ERYTHEMA (Redness) and SWELLING (Swelling) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.

Other Meds: SYNTHROID; VITAMIN 15

Current Illness:

ID: 1580424
Sex: F
Age: 68
State: LA

Vax Date: 01/21/2021
Onset Date: 01/22/2021
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Injection site pain

Symptoms: Rash; swelling; small bruise; itch; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Rash), SWELLING (swelling), CONTUSION (small bruise) and PRURITUS (itch) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. Concomitant products included LEVOTHYROXINE, LOSARTAN, AMLODIPINE, FENOFIBRATE, AMOXICILLIN TRIHYDRATE, CLARITHROMYCIN, ESOMEPRAZOLE MAGNESIUM (NEXIUM), ACYCLOVIR [ACICLOVIR], ESTRADIOL, CALCIUM, CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D) and BUSPIRONE for an unknown indication. On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced RASH (Rash), SWELLING (swelling), CONTUSION (small bruise) and PRURITUS (itch). At the time of the report, RASH (Rash), SWELLING (swelling), CONTUSION (small bruise) and PRURITUS (itch) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.

Other Meds: LEVOTHYROXINE; LOSARTAN; AMLODIPINE; FENOFIBRATE; NEXIUM; ACYCLOVIR [ACICLOVIR]; ESTRADIOL; CALCIUM; VITAMIN D; BUSPIRONE

Current Illness:

ID: 1580425
Sex: F
Age: 69
State: IL

Vax Date: 01/19/2021
Onset Date: 01/20/2021
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Injection site induration, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: RED RING 1INCH AROUND INJECTION SITE; Redness at injection site; ITCHING IN INJECTION SITE; Swelling; knot the size of a walnut; This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of SWELLING (Swelling), VACCINATION SITE MASS (knot the size of a walnut), INJECTION SITE ERYTHEMA (RED RING 1INCH AROUND INJECTION SITE), INJECTION SITE ERYTHEMA (Redness at injection site) and INJECTION SITE PRURITUS (ITCHING IN INJECTION SITE) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029K20A) for COVID-19 vaccination. No Medical History information was reported. On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, the patient experienced SWELLING (Swelling) and VACCINATION SITE MASS (knot the size of a walnut). On 28-Jan-2021, the patient experienced INJECTION SITE ERYTHEMA (Redness at injection site) and INJECTION SITE PRURITUS (ITCHING IN INJECTION SITE). On an unknown date, the patient experienced INJECTION SITE ERYTHEMA (RED RING 1INCH AROUND INJECTION SITE). At the time of the report, SWELLING (Swelling), VACCINATION SITE MASS (knot the size of a walnut), INJECTION SITE ERYTHEMA (RED RING 1INCH AROUND INJECTION SITE), INJECTION SITE ERYTHEMA (Redness at injection site) and INJECTION SITE PRURITUS (ITCHING IN INJECTION SITE) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No relevant concomitant medications were reported. No treatment information was provided.

Other Meds:

Current Illness:

ID: 1580426
Sex: F
Age: 45
State:

Vax Date: 01/13/2021
Onset Date: 01/13/2021
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Nausea, Pain, Tachycardia

Symptoms: swelling of her face; numbness in arms; numbness in hands; tingling in her feet; some throat issue, voice hoarse, tight, but not like closing; This spontaneous case was reported by a health care professional (subsequently medically confirmed) and describes the occurrence of SWELLING FACE (swelling of her face), HYPOAESTHESIA (numbness in arms), HYPOAESTHESIA (numbness in hands), PARAESTHESIA (tingling in her feet) and DYSPHONIA (some throat issue, voice hoarse, tight, but not like closing) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20a) for COVID-19 vaccination. The patient's past medical history included Hysterectomy. On 13-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Jan-2021, the patient experienced SWELLING FACE (swelling of her face), HYPOAESTHESIA (numbness in arms), HYPOAESTHESIA (numbness in hands), PARAESTHESIA (tingling in her feet) and DYSPHONIA (some throat issue, voice hoarse, tight, but not like closing). On 26-Jan-2021, SWELLING FACE (swelling of her face), HYPOAESTHESIA (numbness in arms), HYPOAESTHESIA (numbness in hands), PARAESTHESIA (tingling in her feet) and DYSPHONIA (some throat issue, voice hoarse, tight, but not like closing) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Treatment details steroids and EPI-Pen.

Other Meds:

Current Illness:

ID: 1580427
Sex: M
Age:
State: NH

Vax Date: 01/22/2021
Onset Date: 01/23/2021
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Tremor

Symptoms: Sore arm; Flu symptoms (cough); This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm) and INFLUENZA (Flu symptoms (cough)) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination. No Medical History information was reported. On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Jan-2021, the patient experienced PAIN IN EXTREMITY (Sore arm) and INFLUENZA (Flu symptoms (cough)). On 24-Jan-2021, PAIN IN EXTREMITY (Sore arm) had resolved. At the time of the report, INFLUENZA (Flu symptoms (cough)) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Concomitant medications was not reported. No treatment details was provided. This case was linked to MOD21-034179, US-MODERNATX, INC.-MOD-2021-018287 (Linked Report).; Sender's Comments: MOD21-034179: US-MODERNATX, INC.-MOD-2021-018287:

Other Meds:

Current Illness:

ID: 1580428
Sex: F
Age: 41
State: CT

Vax Date: 01/06/2021
Onset Date: 01/06/2021
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Erythema, Pruritus

Symptoms: Headache; Nausea; Fatigue; Soreness; BP higher than normal; This spontaneous case was reported by an other health care professional and describes the occurrence of HEADACHE (Headache), NAUSEA (Nausea), FATIGUE (Fatigue), PAIN (Soreness) and HYPERTENSION (BP higher than normal) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination. The patient's past medical history included No adverse event. Concomitant products included ESCITALOPRAM OXALATE (LEXAPRO) for an unknown indication. On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Jan-2021, the patient experienced HEADACHE (Headache), NAUSEA (Nausea), FATIGUE (Fatigue), PAIN (Soreness) and HYPERTENSION (BP higher than normal). At the time of the report, HEADACHE (Headache), NAUSEA (Nausea), FATIGUE (Fatigue), PAIN (Soreness) and HYPERTENSION (BP higher than normal) outcome was unknown. Not Provided DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 04-Jan-2021, SARS-CoV-2 test: negative (Negative) Negative. On 12-Jan-2021, SARS-CoV-2 test: negative (Negative) Negative. On 21-Jan-2021, SARS-CoV-2 test: negative (Negative) Negative. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Concomitant medications included Birth control, multi vitamins. Treatment information was not provided.

Other Meds: LEXAPRO

Current Illness:

ID: 1580429
Sex: F
Age: 76
State: NC

Vax Date: 02/02/2021
Onset Date: 02/03/2021
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site induration, Injection site pruritus, Injection site swelling, Myalgia

Symptoms: Burning up; Shivering; Feverish 104.6; This spontaneous case was reported by a consumer and describes the occurrence of BURNING SENSATION (Burning up), CHILLS (Shivering) and PYREXIA (Feverish 104.6) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 02-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, the patient experienced BURNING SENSATION (Burning up), CHILLS (Shivering) and PYREXIA (Feverish 104.6). At the time of the report, BURNING SENSATION (Burning up), CHILLS (Shivering) and PYREXIA (Feverish 104.6) outcome was unknown. Concomitant product use was not provided by the reporter. Treatment information was not provided.

Other Meds:

Current Illness:

ID: 1580430
Sex: F
Age: 66
State: GA

Vax Date: 01/16/2021
Onset Date: 01/16/2021
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Cough, Limb discomfort, Pain, SARS-CoV-2 test positive

Symptoms: This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Swollen arm), DIARRHOEA (Diarrhea), MYALGIA (Body ache), PYREXIA (Fever) and CHILLS (Chills) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In February 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 16-Jan-2021, the patient experienced DIARRHEA (Diarrhea) and PYREXIA (Fever). On 17-Jan-2021, the patient experienced PERIPHERAL SWELLING (Swollen arm), MYALGIA (Body ache) and CHILLS (Chills). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency and IBUPROFEN for Adverse event, at an unspecified dose and frequency. At the time of the report, PERIPHERAL SWELLING (Swollen arm), DIARRHEA (Diarrhea), MYALGIA (Body ache), PYREXIA (Fever) and CHILLS (Chills) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) and mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medications were not provided. This case was linked to MOD-2021-091059 (Patient Link). Most recent FOLLOW-UP information incorporated above includes: On 16-Apr-2021: Information regarding the Email Address was updated.

Other Meds:

Current Illness:

ID: 1580431
Sex: F
Age: 85
State: FL

Vax Date: 01/25/2021
Onset Date: 02/02/2021
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Asthenia, Chills, Headache, Myalgia

Symptoms: Sore(at the injection site); Redness (at the injection site); pain at injection site; Itchiness; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itchiness), MYALGIA (Sore(at the injection site)), INJECTION SITE ERYTHEMA (Redness (at the injection site)) and INJECTION SITE PAIN (pain at injection site) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination. No Medical History information was reported. On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, the patient experienced PRURITUS (Itchiness), INJECTION SITE ERYTHEMA (Redness (at the injection site)) and INJECTION SITE PAIN (pain at injection site). On an unknown date, the patient experienced MYALGIA (Sore(at the injection site)). At the time of the report, PRURITUS (Itchiness), MYALGIA (Sore(at the injection site)), INJECTION SITE ERYTHEMA (Redness (at the injection site)) and INJECTION SITE PAIN (pain at injection site) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medication details were not reported by the reporter. Treatment details was not reported by the reporter.

Other Meds:

Current Illness:

ID: 1580432
Sex: M
Age: 86
State: MI

Vax Date: 02/01/2021
Onset Date: 02/02/2021
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pain, Injection site swelling

Symptoms: shakes; slept a lot; chills; This spontaneous case was reported by a consumer and describes the occurrence of TREMOR (shakes), SOMNOLENCE (slept a lot) and CHILLS (chills) in an 86-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 029L20A and 0101A21A) for COVID-19 vaccination. The patient's past medical history included Clot blood and Gout. Concurrent medical conditions included Deep vein thrombosis, Atrial fibrillation and High cholesterol. Concomitant products included APIXABAN (ELIQUIS) for Anticoagulant therapy, ALOPURINOL for Gout, ALIROCUMAB (PRALUENT) for High cholesterol, UBIDECARENONE (COQ10 [UBIDECARENONE]) and VITAMIN D3 for an unknown indication. On 01-Feb-2021 at 10:30 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, the patient experienced TREMOR (shakes), SOMNOLENCE (slept a lot) and CHILLS (chills). On 02-Feb-2021, TREMOR (shakes), SOMNOLENCE (slept a lot) and CHILLS (chills) had resolved. Treatment medication was not reported for the events. Most recent FOLLOW-UP information incorporated above includes: On 20-Apr-2021: Follow-up received, patient medical history, product details. On 07-Aug-2021: Non Significant Follow-up

Other Meds: PRALUENT; ALOPURINOL; COQ10 [UBIDECARENONE]; VITAMIN D3; ELIQUIS

Current Illness: Atrial fibrillation; Deep vein thrombosis; High cholesterol

ID: 1580433
Sex: F
Age: 91
State: MI

Vax Date: 01/21/2021
Onset Date: 01/21/2021
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Chills, Feeling cold, Feeling hot, Myalgia, Pain

Symptoms: Hips and back began to hurt after the vaccine; Hips and back began to hurt after the vaccine; This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (Hips and back began to hurt after the vaccine) and ARTHRALGIA (Hips and back began to hurt after the vaccine) in a 91-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 immunization. Concurrent medical conditions included Arthritis. On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced BACK PAIN (Hips and back began to hurt after the vaccine) and ARTHRALGIA (Hips and back began to hurt after the vaccine). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, BACK PAIN (Hips and back began to hurt after the vaccine) and ARTHRALGIA (Hips and back began to hurt after the vaccine) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medication details were not reported by the reporter.

Other Meds:

Current Illness: Arthritis

ID: 1580434
Sex: F
Age: 83
State: MD

Vax Date: 01/21/2021
Onset Date:
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Pain in extremity

Symptoms: nose hurts; ear hurts; temple hurts; white flashes on the side of her head; loose stools; shoulder pain; bad headache; nausea; This spontaneous case was reported by a consumer and describes the occurrence of NASAL INJURY (nose hurts), EAR PAIN (ear hurts), FACIAL PAIN (temple hurts), HOT FLUSH (white flashes on the side of her head) and DIARRHOEA (loose stools) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Concurrent medical conditions included Migraine (Ocular migraines). Concomitant products included PARACETAMOL (TYLENOL) and CAFFEINE for Migraine. On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced NASAL INJURY (nose hurts), EAR PAIN (ear hurts), FACIAL PAIN (temple hurts), HOT FLUSH (white flashes on the side of her head), DIARRHOEA (loose stools), ARTHRALGIA (shoulder pain), HEADACHE (bad headache) and NAUSEA (nausea). At the time of the report, NASAL INJURY (nose hurts), EAR PAIN (ear hurts), FACIAL PAIN (temple hurts), HOT FLUSH (white flashes on the side of her head), DIARRHOEA (loose stools), ARTHRALGIA (shoulder pain), HEADACHE (bad headache) and NAUSEA (nausea) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Treatment details were not reported by the reporter.

Other Meds: TYLENOL; CAFFEINE

Current Illness: Migraine (Ocular migraines)

ID: 1580435
Sex: M
Age:
State:

Vax Date: 01/22/2021
Onset Date:
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Abnormal behaviour, Adverse reaction, Anger, Asthma

Symptoms: fever on and off all day for quite a while; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever on and off all day for quite a while) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PYREXIA (fever on and off all day for quite a while). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, PYREXIA (fever on and off all day for quite a while) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 103. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Concomitant medications details were not reported by the reporter.

Other Meds:

Current Illness:

ID: 1580436
Sex: F
Age: 86
State: AZ

Vax Date: 02/16/2021
Onset Date: 02/17/2021
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Consciousness fluctuating, Crying, Dry skin, Epistaxis, Headache

Symptoms: Hot to the touch Injection Site; Redness (3" around Injection Site); Borderline Diarrhea; Fever 100 F; Nausea; Vomiting; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Borderline Diarrhea), VACCINATION SITE WARMTH (Hot to the touch Injection Site), VACCINATION SITE ERYTHEMA (Redness (3" around Injection Site)), PYREXIA (Fever 100 F) and NAUSEA (Nausea) in an 86-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Feb-2021, the patient experienced PYREXIA (Fever 100 F), NAUSEA (Nausea) and VOMITING (Vomiting). On 18-Feb-2021, the patient experienced DIARRHOEA (Borderline Diarrhea). On 19-Feb-2021, the patient experienced VACCINATION SITE WARMTH (Hot to the touch Injection Site) and VACCINATION SITE ERYTHEMA (Redness (3" around Injection Site)). At the time of the report, DIARRHOEA (Borderline Diarrhea), VACCINATION SITE WARMTH (Hot to the touch Injection Site), VACCINATION SITE ERYTHEMA (Redness (3" around Injection Site)) and VOMITING (Vomiting) outcome was unknown and PYREXIA (Fever 100 F) and NAUSEA (Nausea) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medication details were not reported by the reporter. Treatment details was not reported by the reporter.

Other Meds:

Current Illness:

ID: 1580437
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Hypotonia, Lethargy, Respiratory rate decreased, Screaming, Skin warm

Symptoms: ADVERSE REACTION; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE REACTION (ADVERSE REACTION) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ADVERSE REACTION (ADVERSE REACTION). At the time of the report, ADVERSE REACTION (ADVERSE REACTION) outcome was unknown. Concomitant medications details were not reported by the reporter. Treatment details was not reported by the reporter.

Other Meds:

Current Illness:

ID: 1580438
Sex: U
Age: 85
State: OH

Vax Date: 01/27/2021
Onset Date: 01/27/2021
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Vomiting

Symptoms: Headache; Chills; Poor sleep; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of POOR QUALITY SLEEP (Poor sleep), FATIGUE (Fatigue), HEADACHE (Headache) and CHILLS (Chills) in an 85-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination. The patient's past medical history included Stent placement. Concurrent medical conditions included Hypertension and Thyroid disorder. On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, the patient experienced POOR QUALITY SLEEP (Poor sleep) and FATIGUE (Fatigue). On 28-Jan-2021, the patient experienced HEADACHE (Headache) and CHILLS (Chills). At the time of the report, POOR QUALITY SLEEP (Poor sleep), FATIGUE (Fatigue), HEADACHE (Headache) and CHILLS (Chills) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No relevant concomitant medications were reported. No treatment was reported. Reporter did not allow further contact; Sender's Comments: Based on the information provided, a strong temporal association and the established safety profile of mRNA-1273 vaccine, a causal association between the reported events and the product use cannot be excluded. Headache, fatigue and chills are consistent with the known safety profile of the vaccine

Other Meds:

Current Illness: Hypertension; Thyroid disorder

ID: 1580439
Sex: M
Age:
State: NY

Vax Date: 01/05/2021
Onset Date: 02/02/2021
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Headache, Limb discomfort, Nasal congestion

Symptoms: Stomach Pain; Fever; Chills; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN UPPER (Stomach Pain), PYREXIA (Fever), CHILLS (Chills) and FATIGUE (Fatigue) in a 34-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 05-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1. On 02-Feb-2021, the patient experienced ABDOMINAL PAIN UPPER (Stomach Pain), PYREXIA (Fever), CHILLS (Chills) and FATIGUE (Fatigue). At the time of the report, ABDOMINAL PAIN UPPER (Stomach Pain), PYREXIA (Fever), CHILLS (Chills) and FATIGUE (Fatigue) outcome was unknown. Concomitant medications details were not reported by the reporter. Treatment details was not reported by the reporter.

Other Meds:

Current Illness:

ID: 1580440
Sex: F
Age:
State: TX

Vax Date: 01/04/2021
Onset Date:
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Back pain, Cold sweat, Headache, Nausea, Vomiting

Symptoms: burning sensation in the vaginal area; Eyes dry out; Patient stated she put eye drops in her eyes, used it more times than before; This spontaneous case was reported by a health care professional and describes the occurrence of BURNING SENSATION (burning sensation in the vaginal area), DRY EYE (Eyes dry out) and EYE DROP INSTILLATION (Patient stated she put eye drops in her eyes, used it more times than before) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025L20A and 010U20A) for COVID-19 vaccination. No medical history was reported by the reporter. Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID), PRAVASTATIN, SEMAGLUTIDE (OZEMPIC), Tremidon, METHOCARBAMOL (ROBAXIN) and triamrenecholorathiazaide-diuretic for an unknown indication. On 04-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced BURNING SENSATION (burning sensation in the vaginal area), DRY EYE (Eyes dry out) and EYE DROP INSTILLATION (Patient stated she put eye drops in her eyes, used it more times than before). At the time of the report, BURNING SENSATION (burning sensation in the vaginal area), DRY EYE (Eyes dry out) and EYE DROP INSTILLATION (Patient stated she put eye drops in her eyes, used it more times than before) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Treatment details included eye drops.

Other Meds: SYNTHROID; PRAVASTATIN; OZEMPIC; Tremidon; ROBAXIN; triamrenecholorathiazaide-diuretic

Current Illness:

ID: 1580441
Sex: F
Age: 67
State: KS

Vax Date: 02/18/2021
Onset Date: 02/18/2021
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Injection site swelling, Limb discomfort

Symptoms: Warm sensation in the chest and the body 10 minutes after the vaccine.; This spontaneous case was reported by a consumer and describes the occurrence of FEELING HOT (Warm sensation in the chest and the body 10 minutes after the vaccine.) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Feb-2021, the patient experienced FEELING HOT (Warm sensation in the chest and the body 10 minutes after the vaccine.). At the time of the report, FEELING HOT (Warm sensation in the chest and the body 10 minutes after the vaccine.) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Concomitant product use was not provided by the reporter. Treatment details was not reported by the reporter.

Other Meds:

Current Illness:

ID: 1580442
Sex: M
Age: 72
State: WI

Vax Date: 02/14/2021
Onset Date: 02/15/2021
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Chills, Diarrhoea, Fatigue, Feeling abnormal, Headache

Symptoms: fatigue/flat on my back in bed; chills; injection site reaction lymph node swelling under arm; Fever; Muscle aches; Pain at the injection site; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 19-Feb-2021 and was forwarded to Moderna on 19-Feb-2021. This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (fatigue/flat on my back in bed), CHILLS (chills), INJECTION SITE LYMPHADENOPATHY (injection site reaction lymph node swelling under arm), PYREXIA (Fever) and MYALGIA (Muscle aches) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 006M20A and 032M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included COVID-19 on 03-Nov-2020. Concurrent medical conditions included Food allergy (Trout), Hypertension since 15-Sep-1998, Sinusitis since 01-Sep-2014, Obesity (Weight gain due to inactivity.) since 20-Aug-1948, Seasonal allergy since 20-Aug-1956 and Arthritis since 20-Aug-2005. Concomitant products included MONTELUKAST SODIUM (MONTELUCAST) from 15-Mar-2017 to an unknown date for Allergy, MELOXICAM from 15-Oct-2012 to an unknown date for Arthritis, SIMVASTATIN from 20-Oct-2010 to an unknown date for Hyperlipidaemia, HYDROCHLOROTHIAZIDE, VALSARTAN (VALSARTAN/HYDROCHLOROTHIAZIDE) from 14-Nov-2014 to an unknown date and AMLODIPINE from 05-Oct-2020 to an unknown date for Hypertension, AMOXICILLIN TRIHYDRATE, CLAVULANATE POTASSIUM (AMOXICILLIN/CLAVULANIC ACID) from 09-Sep-2017 to an unknown date for Sinusitis. On 14-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 15-Feb-2021, the patient experienced FATIGUE (fatigue/flat on my back in bed), CHILLS (chills), INJECTION SITE LYMPHADENOPATHY (injection site reaction lymph node swelling under arm), PYREXIA (Fever), MYALGIA (Muscle aches) and VACCINATION SITE PAIN (Pain at the injection site). On 16-Feb-2021, FATIGUE (fatigue/flat on my back in bed), CHILLS (chills), PYREXIA (Fever) and MYALGIA (Muscle aches) had resolved. On 18-Feb-2021, INJECTION SITE LYMPHADENOPATHY (injection site reaction lymph node swelling under arm) had resolved. At the time of the report, VACCINATION SITE PAIN (Pain at the injection site) had resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 03-Nov-2020, SARS-CoV-2 test: (Positive) Type of test : Nasal swab. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No treatment details were reported. This case was linked to MOD-2021-096947 (Patient Link). Reporter did not allow further contact Most recent FOLLOW-UP information incorporated above includes: On 28-Apr-2021: This Follow-up was received on 28-APR-2021 which updated patient demographics, lab details, concomitant medications and event details.

Other Meds: AMOXICILLIN/CLAVULANIC ACID; VALSARTAN/HYDROCHLOROTHIAZIDE; AMLODIPINE; MELOXICAM; MONTELUCAST; SIMVASTATIN

Current Illness: Arthritis; Food allergy (Trout); Hypertension; Obesity (Weight gain due to inactivity.); Seasonal allergy; Sinusitis

ID: 1580443
Sex: F
Age:
State:

Vax Date: 01/17/2021
Onset Date: 01/17/2021
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Hot flush, Myalgia, Nausea, Tension headache

Symptoms: Itching; Flu like symptoms; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu like symptoms) and PRURITUS (Itching) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination. No Medical History information was reported. On 17-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Jan-2021, the patient experienced INFLUENZA LIKE ILLNESS (Flu like symptoms). On 25-Jan-2021, the patient experienced PRURITUS (Itching). At the time of the report, INFLUENZA LIKE ILLNESS (Flu like symptoms) and PRURITUS (Itching) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medications details were not reported by the reporter. Treatment details was not reported by the reporter.

Other Meds:

Current Illness:

Total 2021 VAERS Injuries: 704,237

Page last modified: 26 October 2021 2:21am